Though directly comparing the HbA1c reduction of different GLP-1 RAs is challenging, several head-to-head clinical studies have provided insight into differences between these products based on the pharmacodynamic and efficacy results from clinical trials [118]
[The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]
Khng lm dng glutathione vi liu lng qu cao, c th gy ra tc dng ph nh au bng, chng bng, kh th
[DOI] [PubMed] [Google Scholar] 174.Balasundaram G, Shimpi TM, Sanow WR, Storey DM, Kitchell BS, Webster TJ
Badawy et al., 2002
For researchers concerned about cardiovascular risk, practical strategies to minimize TMAO production include supporting a healthy gut microbiome through prebiotic and probiotic use, monitoring TMAO levels if testing is available, and keeping total levocarnitine exposure within studied safety ranges